Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.
about
Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?Clinical Use of Diuretics in Heart Failure, Cirrhosis, and Nephrotic SyndromeHyponatremia in cirrhosis: pathophysiology and managementDifferential efficacy profile of aldosterone receptor antagonists, depending on the type of chronic heart failure, whether with reduced or preserved left ventricular ejection fraction-results of a meta-analysis of randomized controlled trialsElectrolytes in the aging.Region-specific changes in transient receptor potential vanilloid channel expression in the vasopressin magnocellular system in hepatic cirrhosis-induced hyponatraemia.The impact of maternal protein restriction during rat pregnancy upon renal expression of angiotensin receptors and vasopressin-related aquaporins.ANG II receptor subtype 1a gene knockdown in the subfornical organ prevents increased drinking behavior in bile duct-ligated ratsDehydration followed by sham rehydration contributes to reduced neuronal activation in vasopressinergic supraoptic neurons after water deprivation.Tolvaptan, hyponatremia, and heart failure.Differential regulation of TRPC4 in the vasopressin magnocellular system by water deprivation and hepatic cirrhosis in the ratMineralocorticoid receptor antagonists as diuretics: Can congestive heart failure learn from liver failure?Diverse roles of G-protein coupled receptors in the regulation of neurohypophyseal hormone secretion.Pulmonary hypertension, right ventricular failure, and kidney: different from left ventricular failure?ΔFosB in the supraoptic nucleus contributes to hyponatremia in rats with cirrhosis.Hyponatremia in the intensive care unit: How to avoid a Zugzwang situation?Fluid overload and changes in serum creatinine after cardiac surgery: predictors of mortality and longer intensive care stay. A prospective cohort studyIntracerebroventricular losartan infusion modulates angiotensin II type 1 receptor expression in the subfornical organ and drinking behaviour in bile-duct-ligated rats.Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension.Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertensionAltered central TRPV4 expression and lipid raft association related to inappropriate vasopressin secretion in cirrhotic rats.Diagnosis and management of hyponatremia in acute illnessRole of vasopressin and aldosterone in pulmonary arterial hypertension: A pilot study.Cardiac and systemic haemodynamic complications of liver cirrhosis.Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH).Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I.Vaptans for the treatment of hyponatremia.The potential role for lixivaptan in heart failure and in hyponatremia.Experimental biomarkers in heart failure: an update.Physiology of the female reproductive axis.Therapeutic implications of biomarkers in chronic heart failure.Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes.Copeptin as a biomarker in heart failure.Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspectsAcid-base and electrolyte abnormalities in heart failure: pathophysiology and implications.Employment of vasopressin receptor antagonists in management of hyponatraemia and volume overload in some clinical conditions.Vasopressin regulation of sodium transport in the distal nephron and collecting duct.Cirrhotic Multiorgan Syndrome.Role of superior laryngeal nerve and Fos staining following dehydration and rehydration in the rat.The Changing Role of Sodium Management in Cirrhosis.
P2860
Q26778032-C429F226-DBB5-4769-8D80-25FD5104C2B7Q26796104-FA5384B1-8CB1-4B76-9D25-7A93991F06A2Q27027861-18E49757-FBD6-4520-AE8B-4F42C0F198B9Q33714645-A60FD841-79CA-451C-8C55-F00064AFC72CQ33980993-069EA160-0695-4A1F-A8C4-CF4D369659DDQ34107621-0B0966A8-4CD4-48BB-8327-8C68C536A614Q34133527-6D45A260-C56B-4E03-94FD-A181E2CDF4C1Q34201130-B6A59B3B-9F3C-4DBB-A0F3-08E10B0CC3B1Q34305751-C83EA2DA-0E41-46DC-A4D8-97FF1A3958CCQ35026759-9F222715-94E8-43CB-8EB6-BE639CA17F27Q35071589-D82AA49F-AC91-4D88-9A36-3C411F4FAFE8Q35272248-138CE9E7-A248-4BE8-8A98-B9F36AB9E186Q35856948-4DAADFCE-9E29-4A90-BE7F-FA5695016C60Q36063303-D66C6BAB-FAA6-4750-BDE2-E04B15B5454BQ36115274-B7C53ED5-9420-4C2B-99DE-BE5D412F6C2BQ36265206-DBE29DC6-798F-4E70-9966-EBAB68351DA9Q36633675-5ECD1A94-6341-45AD-8B9D-4FA834AC2299Q36711459-A59F7BB6-F1AF-4CA8-8BE2-E4469596605CQ36718655-637966AD-8A4F-4F79-8A52-309DE3AE6E35Q36974139-B1FCE1DE-024C-418F-8286-68AEA28A900CQ37100471-9B8731B7-275C-4967-9D5B-973AA0E96DD6Q37277688-3A349867-1364-4D3F-91FD-C91CDBFD7BAFQ37308522-63632D72-2F76-4433-B06F-F05010DCC0A6Q37368987-2E2E4634-8BDF-408F-AFF0-C0DDA16B6719Q37799214-4528C6A9-57E0-4010-8344-C21C0437E2A5Q37832481-86B8B29C-4FC8-43EC-B6C2-C38A063C828DQ37833895-1B97243C-D06A-4C58-9FFA-E4A38C497943Q37872778-3A996819-0F90-4569-959E-7DB9D0657536Q38055505-F9DC332C-0D3B-4C72-800F-5800ABE55845Q38067474-162C6F42-8CE0-40E0-9BEB-ECE2522090C3Q38121720-6000D49A-C5F9-4CDD-8146-00582131C39EQ38199770-89C5BE07-EF3F-49CD-BE10-D48FFB8CEA00Q38249996-92B13ED9-65FA-4DC1-B692-D069FA9C98B3Q38268612-EDE76E8C-F98D-4AAE-8EDA-CBCAB3CEA9F5Q38395162-F1B96D57-5427-4500-9F57-FDEFD0800DC9Q38449311-4E86A5AB-FD74-4D74-8D46-7FDFE21C6D99Q38515104-35FDFA70-7E72-44B6-A862-2E3E9BFC5696Q38538183-56CB44EC-E07A-4203-AD5E-FA9CEE04F2C7Q38594109-037D7640-43E6-4DF0-BF04-C8F2DFA45FF7Q38796241-DFE83EB2-278E-41BD-907E-3F1FE5CE0106
P2860
Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.
@ast
Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.
@en
type
label
Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.
@ast
Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.
@en
prefLabel
Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.
@ast
Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.
@en
P1476
Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.
@en
P304
P356
10.1016/J.AMJMED.2006.05.007
P407
P433
P577
2006-07-01T00:00:00Z